ArticleLipids2025
Lipid and lipoprotein particle profiles in patients with type 2 diabetes mellitus: A comparative study between highlanders and lowlanders.
Article in Lipids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synergistic Effects of Diabetes, Inflammatory/Coagulopathy Biomarkers, TG and Hypoxic Stress on Premature Coronary Heart Disease in High-Altitude Populations.Journal of cardiovascular development and disease · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The lipid profiles of highlanders and lowlanders differ. However, studies of the lipid profiles of patients with type 2 diabetes mellitus (T2DM) living at high altitudes are limited. This study aimed to compare lipid profiles and lipoprotein particles in individuals with T2DM permanently residing in the Tibetan Plateau and those residing in the lowlands. This cross-sectional study included 117 individuals with T2DM from the lowlands (n = 78) and highlands (n = 39). Demographic information, clinical features, blood biochemical indices, and standard lipid concentrations were recorded and evaluated. Low-density lipoprotein particles (LDL-Ps) and LDL subfractions were compared between the groups. Additionally, the risk for atherosclerotic cardiovascular disease (ASCVD) was assessed. The standard lipid profile and nuclear magnetic resonance-measured lipid panel showed no significant differences in terms of triglyceride, total cholesterol, and high-density lipoprotein cholesterol levels. However, highlanders exhibited a higher mean level of LDL cholesterol (LDL-C) than lowlanders. The LDL-P mean level was significantly higher in highlanders than in lowlanders. Small-density LDL (sdLDL) showed no distinct difference between the two groups. Furthermore, the 10-year risks of ASCVD were slightly higher in highlanders than in lowlanders, although the difference was not statistically significant. Individuals with T2DM living at highland altitudes have higher LDL-C and LDL-P levels than those living in lowlands. No difference was observed in the sdLDL levels between the two populations. These discrepancies may carry profound implications for the clinical management of T2DM and the prevention of cardiovascular diseases in high-altitude areas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.